REVANESSE® KISS™ with Lidocaine

Key Uses of Revanesse Kiss with Lidocaine

Revanesse Kiss with Lidocaine dermal filler is primarily used for lip enhancement and perioral rejuvenation. It is recommended for:

• Lip augmentation: Enhancing lip volume for a fuller, natural look.
• Lip contouring: Improving the shape and definition of the lips.
• Hydration and smoothness: Adding moisture and improving lip texture.
• Correction of fine lines around the lips: Reducing vertical lip lines and smoker’s lines.

Manufacturing Information for Revanesse Kiss with Lidocaine

Prollenium Medical Technologies based in Ontario, Canada, develops and produces Revanesse Kiss in ISO-certified facilities to ensure the highest safety standards.

Other fillers in the Revanesse range include:

• Revanesse Pure: A non-crosslinked HA filler for deep skin hydration.
• Revanesse Shape+: Designed for deep tissue augmentation, providing structural support.
• Revanesse Ultra: A highly elastic filler for deep wrinkles and facial contouring.

Revanesse Contour: A firm filler designed for facial sculpting and contouring.

Expected Benefits and Results of the Treatments

Patients undergoing Revanesse Kiss with Lidocaine treatment can expect the following benefits:

• Enhanced lip volume: Increases lip fullness while maintaining a soft and natural feel.
• Defined lip contour: Improves lip shape and symmetry for a more refined look.
• Smooths fine lines: Effectively reduces vertical lip lines, commonly known as smoker’s lines.
• Hydrates and rejuvenates lips: Hyaluronic acid retains moisture, improving lip texture and preventing dryness.
• Minimised discomfort during treatment: Lidocaine provides a pain-relieving effect, making the injection process more comfortable.
• Soft and elastic consistency: Ensures smooth and even distribution, reducing the risk of lumps.
• Low swelling and bruising: The filler’s unique formulation minimises post-injection swelling, allowing for faster recovery.
• Long-lasting effects: Results typically last between 6 to 9 months, reducing the need for frequent touch-ups.
• Biodegradable and naturally absorbed: Over time, the filler dissolves safely without leaving residues in the tissue.
• Minimal downtime: Most patients can return to their daily activities shortly after treatment.

Included Items or Accessories

Each Revanesse Kiss with Lidocaine package contains:

• 2 x 1 ml pre-filled syringes.
• 2 x 27G1/2” sterile needles.
• Instructions and safety information leaflets.
• Traceability labels for patient records.

Administration Method for Revanesse Kiss with Lidocaine

Medical professionals must follow strict procedures to ensure optimal results:

Pre-procedure:

• Assess patient suitability and discuss expectations.
• Cleanse the treatment area thoroughly.
• Apply numbing cream if necessary.

During procedure:

• Use a fine-gauge needle for precision.
• Inject slowly to ensure even distribution.
• Monitor for any immediate reactions.

After procedure:

• Gently massage the area to ensure uniformity.
• Provide aftercare instructions.
• Schedule follow-up if needed.

Guidelines for Proper Aftercare

Patients should follow these aftercare guidelines for the best results:

• Avoid touching or massaging the treated area for 24 hours.
• Stay hydrated to enhance filler longevity.
• Avoid extreme temperatures (saunas, sun exposure) for 48 hours.
• Refrain from intense physical activity for 24 hours.

Duration of Revanesse Kiss with Lidocaine Effects

The effects typically last between 6 to 12 months, depending on metabolism, lifestyle, and treatment area. Touch-up treatments are recommended every 6 months to maintain results.

Revanesse Kiss with Lidocaine Treatment Contraindications

Revanesse Kiss with Lidocaine is an effective dermal filler, but it may not be suitable for all patients. Certain medical conditions and circumstances may increase the risk of complications, including:

• Individuals with severe allergies or anaphylaxis history: Patients with a history of severe allergic reactions, especially to lidocaine or hyaluronic acid, should not undergo this procedure.
• Patients with active skin infections or inflammation: If the patient has cold sores, acne, or other infections in the treatment area, the procedure should be postponed until the skin has fully healed.
• People with bleeding disorders or on blood thinners: Patients taking anticoagulants or those with haemophilia have a higher risk of excessive bruising or prolonged bleeding.
• Individuals with autoimmune diseases: Patients with conditions like lupus, rheumatoid arthritis, or multiple sclerosis may have an increased risk of adverse reactions.
• Pregnant or breastfeeding women: The safety of dermal fillers during pregnancy or breastfeeding has not been established, so treatment should be avoided.
• History of keloid or hypertrophic scarring: Those prone to excessive scarring should avoid dermal filler treatments.
• Previous allergic reactions to lidocaine or dermal fillers: Patients with known allergies to local anaesthetics or HA-based fillers should consult a specialist before considering treatment.
• Recent facial surgery or laser treatments: If the patient has had cosmetic surgery, laser resurfacing, or deep chemical peels, they should wait until the skin has fully recovered before receiving dermal fillers.
• Individuals with uncontrolled diabetes: Poor wound healing and increased risk of infection make it unsuitable for diabetics with unmanaged blood sugar levels.
• Patients with compromised immune systems: People undergoing immunosuppressive treatments, such as chemotherapy or corticosteroids, may have a higher risk of infection.
• Those with unrealistic expectations: Patients who expect permanent results or dramatic transformations may not be suitable candidates.